Clinical Trials Directory

Trials / Unknown

UnknownNCT02637817

MRI-based Biomarkers for Predicting Punctate White Matter Lesions in Neonates

MRI-based Biomarkers for the Prognosis Judgement of Punctate White Matter Lesions in Neonates: a Longitudinal Multicenter Study

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
Sex
All
Age
1 Day – 28 Days
Healthy volunteers
Not accepted

Summary

As a common white matter (WM) disease in preterm neonates, punctate white matter lesion (PWML) frequently leads to the abnormalities of brain development (e.g. the motor, visual and auditory disorders), even to cerebral palsy (CP) and amblyopia during childhood. However, it is lack of certain methods in identifying the prognosis of PWML. Through using various advanced MRI techniques, neuro-behavioral and visual assessments, a multicenter longitudinal study would be conducted to follow-up the PWML neonates with varying spatial-position and degree lesions. Through tracking the variations in WM microstructures from neonate period to childhood (2 years old and 3 years old), this study aims to explore (1) the potential relations between varying PWMLs and motor and visual disorders (2) the relations between WM MRI-metrics and neurodevelopmental assessment results, and thus determine the early biomarkers to identify CP and amblyopia.

Conditions

Timeline

Start date
2016-01-01
Primary completion
2019-06-01
Completion
2019-12-01
First posted
2015-12-22
Last updated
2018-06-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02637817. Inclusion in this directory is not an endorsement.